C646, a histone acetyltransferase p300 inhibitor acting as a p53 activation inhibitor, significantly increased viral production in p53 wild-type cancer cells (Fig. 4K), and decreased cell viability (Fig. 4L), suggesting that inhibition of p53 activation also enhanced cell death derived from viral lysis. Here, EP300 is linked to cancer.